Immunotherapeutic applications of CpG-ODN as TLR9 agonists include not only approaches to enhance immune responses, but also immunosuppressive strategies, as is the case for treating allergy [2] and autoimmunity [3]. Here, TLR9 is linked to Autoimmunity.